Cite

    Moore, K. et al. (n.d.). Rivaroxaban crushed tablet suspension characteristics and relative bioavailability in healthy adults when administered orally or via nasogastric tube. Clinical pharmacology in drug development. 3 (4), pp. 321-327. [Online].